Virginia Subcommittee Approves Psilocybin Rescheduling Bill

Virginia Subcommittee Approves Psilocybin Rescheduling Bill

Virginia Senator Gazala Hashmi’s bill, Senate Bill 932which was recently passed by the Senate Education and Health Subcommittee on Jan. 25. Hashmi explains how many psilocybin bills have been introduced across the country, the importance of allowing patients psilocybin, and more. , told the subcommittee about what the bill would provide.

“Mr. Chairman, this is SB-932 and it addresses the issue of helping our community members who need medication to deal with their PTSD and depression issues, but other medications are It doesn’t really help them and help them address their critical needs.” Hashimi said at the conference“Last year, I introduced legislation to decriminalize psilocybin, which has proven to be very effective in treating PTSD and depression problems, especially among veterans. An increasingly compelling study is coming out of Johns Hopkins University [University], from Stanford, demonstrating how effective products are in treating these specific concerns. Many states are already moving to decriminalize psilocybin, and doing so has shown good and effective results. have been obtained. “

The bill authorizes the Virginia Psilocybin Advisory Committee, which is solely responsible for developing “a long-term strategic plan to establish therapeutic access to psilocybin services and to monitor and study federal law, regulation, and policy regarding psilocybin.” proposing to create It also keeps the Advisory Board accountable by setting a December 1 deadline each year to report to the Governor and the General Assembly on “its activities and recommendations.” Finally, if passed, psilocybin will be reclassified from a Schedule I to a Schedule III substance.

Additionally, the measure would direct the governor to appoint 12 members to the board, including mycologists, clinical researchers, and other public health and safety officials.

Possession of Schedule I substances such as psilocybin currently class 5 felony This can result in up to 10 years in prison and a $2,500 fine. Under SB-932, psilocybin would be a Class 1 misdemeanor, punishable by up to one year in prison and he could be fined $2,500.

On January 18, the Senate Judiciary Subcommittee voted against passage. House Bill 1513, another bill that also aimed to establish a regulatory framework for psilocybin as a treatment for medical conditions such as depression and post-traumatic stress disorder. It was reintroduced by Virginia Del. Dawn Adams after a previous iteration failed in 2022.

Psilocybin legislation actually kicks off in 2022, with momentum continuing through 2023.

California Senator Scott Weiner Senate Bill 58, which introduced legislation to decriminalize psilocybin and other plant-based hallucinogens in late December, did not pass.of connecticut, House Bill 5102, aimed at making psilocybin available for therapeutic purposes.Rep. LaSean Ford, introduced as House Bill 0001 On January 12, Illinois will regulate psilocybin. Missouri Representative Tony Lovasco recently introduced House Bill 869 last week, an update to last year’s bill that would allow psilocybin therapy. New Jersey Senate Speaker Nicholas Scutari’s bill from 2022, Building S2934, is being brought up in 2023 to decriminalize psilocybin and introduce an expungement effort. Similar bills have been introduced in Minnesota, Montana and New York. Even lawmakers in Oregon, where voters approved two ballot measures to legalize psilocybin in 2020, continue to introduce new bills to tweak and improve the state’s psilocybin laws.

According to a study published by American Medical Association By December 2022, most states plan to legalize psychedelics between 2034 and 2037. “(1) standards for medicines procured outside of health care facilities, (2) licensing standards for prescribers and therapists, (3) clinical and billing infrastructure, (4) potential contraindications, (5) youth, elderly For use in special populations such as pregnant women, pregnant women, etc.

Alexandra Solorio
Introducing Alexandra, an accomplished cannabis writer who has passionately pursued her craft for a decade. Through a decade-long journey, Alexandra has cultivated a profound connection with the cannabis world, translating her expertise into captivating prose. From unraveling the plant's rich history to exploring its therapeutic marvels and legal evolution, she has adeptly catered to both connoisseurs and newcomers. An unwavering advocate, Alexandra's words not only enlighten but also advocate responsible cannabis use, establishing her as an indispensable industry voice over the past ten years.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *